Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification (Q24241978)

4

0 references

Laura Amato

1

0 references

Silvia Minozzi

2

0 references

author name string

Marica MF Ferri

5

0 references

Soraya Mayet

Cochrane Database of Systematic Reviews

6

0 references

publication date

16 July 2008

0 references

published in

0 references

cites work

Contingent methadone delivery: effects on illicit-opiate use.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Abstinence incentive effects in a short-term outpatient detoxification program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Contingency management interventions: effects on treatment outcome during methadone detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Voucher-based reinforcement of opiate abstinence during methadone detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Integrating skills training and motivational therapies. Implications for the treatment of substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Millon Clinical Multiaxial Inventory-III subtypes of opioid dependence: validity and matching to behavioral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Drug Stroop performance: relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Does Outreach Case Management Improve Patients' Quality of Life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Drug abuse treatment in criminal justice settings: enhancing community engagement and helpfulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Does post-withdrawal cue exposure improve outcome in opiate addiction? A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Attrition prevention with individuals awaiting publicly funded drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

After drug treatment: are 12-step programs effective in maintaining abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Drug treatment and 12-step program participation: the additive effects of integrated recovery activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Network therapy: decreased secondary opioid use during buprenorphine maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Opioid craving and seeking behavior in physically dependent volunteers: effects of acute withdrawal and drug reinforcement opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Contingency management in outpatient methadone treatment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

The effect of a case management intervention on drug treatment entry among treatment-seeking injection drug users with and without comorbid antisocial personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Relationships between counseling rapport and drug abuse treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Impact of role induction on long-term drug treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Outcomes of four treatment approaches in community residential programs for patients with substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Addictive disorders in context: principles and puzzles of effective treatment and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Changes in locus-of-control attitudes about drug misuse in a self-help group in a methadone maintenance clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Marathon groups: facilitating the personal growth of male illicit drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Contingency management for treatment of substance use disorders: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Methadone Transition Treatment: A Treatment Model for 180-Day Methadone Detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Family therapy for Dutch drug abusers: replication of an American study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Comparative outcomes and costs of inpatient care and supportive housing for substance-dependent veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Motivational interviewing and treatment retention among drug user patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Outcome, attrition, and family–couples treatment for drug abuse: A meta-analysis and review of the controlled, comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

A bi-directional theory of addiction: examining coping and the factors related to substance relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Methadone maintenance treatment in opiate dependence: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Substitution treatment of injecting opioid users for prevention of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Buprenorphine for the management of opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Opioid antagonists with minimal sedation for opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Treatment for the Dually Diagnosed Homeless

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

The impact of a brief motivational intervention with opiate users attending a methadone programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

Outpatient mental health care, self-help groups, and patients' one-year treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

Evaluation of out-patient counselling compared with general practitioner care following overdoses

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

Behavioral couples therapy for male substance-abusing patients: effects on relationship adjustment and drug-using behavior.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

Effects of adding behavioral treatment to opioid detoxification with buprenorphine

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and posttreatment findings

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

Efficacy of brief coping skills interventions that match different personality profiles of female substance abusers

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

The influence of psychological factors on the opiate withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

Influence of outpatient treatment and 12-step group involvement on one-year substance abuse treatment outcomes.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

The effectiveness of alternative planned durations of residential drug abuse treatment

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD005031.PUB2

7 January 2021

Psychosocial treatment for opiate abuse and dependence

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD004330.PUB2